Good afternoon, and welcome to Nevro Corp.'s 2021 annual meeting of stockholders. I would now like to introduce Nevro's General Counsel, Kashif Rashid, who will be taking us through today's meeting. Welcome, everyone. Thank you for joining us today. In accordance with our bylaws, I will act as chairperson and secretary of this meeting. As in prior years, we are hosting our annual meeting virtually, which we believe allows us to be more inclusive and reach a greater number of our stockholders who are attending the meeting via the web portal. As is our custom, we will conduct the business portion of our meeting first and answer questions at the end of the meeting. Though we may not be able to answer every question, we will do our best to provide a response to as many as possible. In keeping with the digital approach to this year's meeting, it is now shortly after 10:30 AM Pacific Time on May 25th, and this meeting is officially called to order. First, I'd like to introduce the members of Nevro's board of directors and other members of senior management who are present at today's meeting. From the board of directors, we have Keith Grossman, Michael DeMane, Frank Fischer, Shawn McCormick, Kevin O'Boyle, Karen Prange, Sue Siegel, and Brad Vale. Additionally, besides myself with us today from company management are Roderick MacLeod, Chief Financial Officer, Rich Carter, Vice President of Finance and Corporate Controller, and Julie Dewey, Vice President of Investor Relations and Corporate Communications. We are also joined today by Travis Salha of PricewaterhouseCoopers, our independent auditors. Mr. Salha will be available during the question and answer session after the meeting to respond to appropriate questions. Finally, Nevro has appointed Broadridge Financial Solutions to act as Inspector of Elections. Kathy Wheadon from Broadridge is with us and has taken the oath of Inspector of Elections earlier today. We will now begin the formal business of the annual meeting and vote on the items presented in our 2021 proxy statement. After the polls are closed, the votes will be counted, and preliminary voting results will be announced. After the formal meeting has been adjourned, we will provide time for general questions. Only validated stockholders may ask questions, which must be submitted in the designated field on the web portal. Out of consideration for others, please limit yourself to one question. Please note that this meeting is being recorded. However, no one attending via the webcast is permitted to use any recording device. The board of directors fixed March 30th, 2021, as the record date for determining stockholders entitled to vote at this meeting. I have received an affidavit confirming that the notice of this meeting and the notice of internet availability of our proxy statement and 2020 annual report was mailed on or about April 15th, 2021, to all stockholders as of the record date. The affidavit will be incorporated into the minutes of this meeting. The stockholder list shows that as of the record date, there were 34,692,264 shares of common stock outstanding and entitled to vote at this meeting. We are informed by the Inspector of Elections that there are represented in person or by proxy, at least a majority of the voting power of all issued and outstanding stock entitled to vote on the record date. Accordingly, a quorum is present for purposes of transacting business. Now, I will present the matters to be voted upon, which are listed in our proxy statement. Please note that we will vote after all items have been presented. Proposal one is the election of directors. As described in the proxy statement, Mr. DeMane, Mr. Fischer, Mr. McCormick, Mr. O'Boyle, Ms. Prange, and Dr. Vale have been nominated to serve as directors, and each has chosen to stand for re-election until the 2022 annual meeting of stockholders or until his or her successor is duly elected and qualified. Proposal two is the ratification of the selection by the audit committee of our board of PricewaterhouseCoopers as our independent registered public accounting firm for the year ending December 31st, 2021. Proposal three, which is the final proposal, is the non-binding advisory vote to approve the compensation of our named executive officers as described in our 2021 proxy statement. The polls are now open. Any stockholder who has not yet voted or wishes to change their vote may do so by clicking on the voting button on the web portal and following the instructions there. Stockholders who have sent in proxies or voted via telephone or internet and who do not want to change their vote do not need to take any further action. Now that everyone has had the opportunity to vote, I declare that the polls for Nevro's 2021 annual meeting of stockholders are closed. We have been informed by the Inspector of Election that the preliminary vote report shows that there were sufficient votes for the re-election of each of the nominees, Mr. DeMane, Mr. Fischer, Mr. McCormick, Mr. O'Boyle, Ms. Prange, and Dr. Vale, and each is hereby re-elected to the board. In addition, the Inspector of Election's preliminary vote report shows that each of the other proposals, the ratification of PricewaterhouseCoopers as our independent registered public accounting firm, and the approval on a non-binding advisory basis of the compensation of our named executive officers, have also received sufficient votes, and each has passed. The Inspector of Election will prepare a final report that will be included as part of the record of this meeting. We will be reporting the final vote results in a Form 8-K to be filed with the Securities and Exchange Commission within four business days of this meeting. We have no other business to conduct at this meeting, and the meeting is now closed. We will now proceed to our general Q&A. We would like to open the floor for stockholder questions. We will take stockholder questions that are being entered today on the web portal. Please note we will attempt to answer as many questions as time allows, but only questions that are germane to the meeting will be addressed. There being no questions, we'd like to thank you for attending our annual meeting. We hope you share our excitement about Nevro and look forward to your attendance again next year.